Benefits
Standalone Zeaxanthin from Paprika
OmniXan provides 3R,3'R zeaxanthin from PAPRIKA (Capsicum annum) — useful for formulators wanting zeaxanthin without lutein, or higher zeaxanthin ratios in custom formulations.
Macular Carotenoid
Zeaxanthin is one of three macular carotenoids (alongside lutein and meso-zeaxanthin); deposits in central macula (fovea) where lutein is more peripheral; important for central vision.
Blue Light Filtering
Zeaxanthin absorbs short-wavelength blue light (400-500 nm) protecting retinal photoreceptors from photo-oxidative damage.
Singlet Oxygen Quenching
Among the most potent natural quenchers of singlet oxygen and lipid radicals — relevant to retinal antioxidant defense.
Paprika-Source Distinction
Paprika source provides 3R,3'R zeaxanthin (the dietary form). Note: meso-zeaxanthin (3R,3'S) is sourced from marigold via OmniActive's separate OmniXan-RS product line.
Mechanism of action
Macular Pigment Deposition
Dietary 3R,3'R zeaxanthin deposits in central macular pigment, particularly the fovea — central vision area.
Blue Light Absorption
Zeaxanthin's molecular structure absorbs blue light (400-500 nm), reducing oxidative damage to photoreceptors.
Antioxidant Activity
Quenches singlet oxygen and lipid radicals; recycled by other antioxidants for sustained activity.
Source Distinction
OmniXan paprika-sourced 3R,3'R zeaxanthin is bioequivalent to dietary zeaxanthin from green leafy vegetables and corn; structurally identical.
Clinical trials
Subchronic toxicity and mutagenicity safety evaluation of OmniXan™ paprika-derived RR-zeaxanthin (65%).
Rat models (acute, subchronic toxicity, mutagenicity).
Oral LD50 >2000 mg/kg/day; no adverse effects in subchronic studies; no mutagenic activity. Established safety profile for human supplementation. CRITICAL CAVEAT: this is a safety/toxicology study, not a clinical efficacy trial.
Multiple zeaxanthin trials including AREDS2 component evidence.
Adults including AMD-risk populations.
Established macular pigment building and visual function support. CRITICAL CAVEAT: most evidence from generic zeaxanthin or zeaxanthin+lutein combinations, not OmniXan-specific. Specific OmniXan clinical efficacy trials limited.